Ronald Hoffman

Hematology & Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · ·

History

Myeloproliferative Neoplasms-Research Consortium
National Cancer Institute · P01
Contact PI · $77.9M · Icahn School of Medicine at Mount Sinai
2006–2028
Mechanistic Understanding of Dysregulated Iron Metabolism in Polycythemia Vera
National Institute of Diabetes and Digestive and Kidney Diseases · R56
PI · $100K · Icahn School of Medicine at Mount Sinai
2022–2023
Hematopoietic Potential of Skeletal Muscle Cells
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · University of Illinois at Chicago
2001–2006
Allochimerism Following Haploidentical Stem Cell Transpl
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · University of Illinois at Chicago
1999–2004

Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Principal investigator · Completed · Phase 1, Phase 2
John Mascarenhas
2014–2018
Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai
2012–2016
LBH589 (Panobinostat) for the Treatment of Myelofibrosis
Principal investigator · Unknown · Phase 1, Phase 2
Ronald Hoffman
2009–2015
Clopidogrel and Aspirin for the Treatment of Polycythemia Vera
Principal investigator · Withdrawn · Phase 2
Ronald Hoffman
2009–2011